# Vice President, Medical Affairs at Recursion

- Company: Recursion
- What the company does: Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us today! Backed by SoftBank VF, CRV and Felicis.
- Company website: https://recursion.com/
- Type: Startups (AI role)
- Level: Principal and up
- Location: Remote Opportunity - United States
- Work setup: Remote
- Pay: $359K to $449K base salary per year (USD)
- Posted: 2026-09-21
- Apply by: 2026-11-05
- Apply: https://job-boards.greenhouse.io/recursionpharmaceuticals/jobs/8221491
- Page: https://www.1752.vc/careers/jobs/recursion-vice-president-medical-affairs/

## About the role

At Recursion, we are decoding biology to radically improve lives. As Vice President, Medical Affairs, you will help shape how Recursion translates breakthrough science, clinical data, real-world evidence, and AI-enabled insights into meaningful impact for patients, clinicians, investigators, and health systems.

## What they're looking for

- Advanced clinical or scientific degree required, MD, DO, PharmD, PhD, or equivalent advanced degree strongly preferred
- 15+ years of biotech or pharmaceutical industry experience, including significant leadership experience in Medical Affairs
- Experience building and leading Medical Affairs strategy for clinical-stage or launch-stage assets, ideally in oncology, rare disease, immunology, or other specialty therapeutic areas
- Proven ability to lead integrated evidence planning, including RWE, HEOR, epidemiology, burden-of-disease, natural history, treatment-pattern, outcomes, and value-focused studies
- Demonstrated success in engaging KOLs, investigators, patient advocacy organizations, professional societies, payers/HTA stakeholders, and other external experts through compliant scientific exchange
- Experience developing scientific platforms, publication plans, congress strategies, advisory boards, medical education initiatives, and medical information resources

Tags: Development